Quick Summary
- Shares of Marvell Technology rallied approximately 13% on Tuesday following a strategic Nvidia partnership announcement
- The collaboration includes a $2 billion investment from Nvidia in Marvell
- Marvell’s custom AI processors (XPUs) will integrate with Nvidia’s NVLink Fusion technology platform
- Bank of America Securities upgraded its MRVL price target to $125 from $110 while keeping its Buy recommendation
- A quarterly dividend of $0.06 per share was announced by Marvell, with payment scheduled for April 30, 2026
Shares of Marvell Technology (MRVL) experienced a significant rally of approximately 13% during Tuesday’s trading session after unveiling a substantial strategic alliance with Nvidia (NVDA), which includes a direct $2 billion equity investment from the chip giant. Nvidia’s stock also gained 5.6% during the same session.
Marvell Technology, Inc., MRVL
The collaboration focuses on Nvidia’s NVLink Fusion technology platform, which will seamlessly incorporate Marvell’s specialized AI processors — referred to as XPUs — alongside Nvidia’s computing and networking solutions. This integration enables enterprises to create flexible AI infrastructure by combining components from both manufacturers.
Both technology leaders will deepen their optical technology collaboration through silicon photonics and co-packaged optics innovations, with development plans extending through 2028 and beyond.
Additionally, Marvell and Nvidia intend to collaborate on the telecom AI-RAN sector, transforming telecommunications networks into AI-capable infrastructure supporting 5G and emerging 6G deployments through Nvidia’s Aerial AI-RAN technology platform.
Nvidia’s CEO Jensen Huang stated that “the inference inflection has arrived” and emphasized the explosive growth in token generation demand globally. He highlighted the Marvell collaboration as instrumental in helping enterprises deploy customized AI computing architectures within Nvidia’s technology ecosystem.
Marvell’s CEO Matt Murphy emphasized that this agreement underscores the increasing importance of high-speed connectivity, optical technologies, and sophisticated infrastructure for AI expansion.
Understanding Nvidia’s Strategy Behind the Marvell Partnership
Marvell’s XPU processors are designed for intensive AI workloads — a domain where Nvidia’s GPU technology is dominant. Instead of viewing Marvell as strictly a competitor, Nvidia has opted to create interoperability between its hardware and Marvell’s chip solutions.
This approach creates an environment where enterprises can deploy both technologies within a unified AI infrastructure. Nvidia expands its ecosystem footprint, while Marvell gains credibility and accelerated market penetration.
Bank of America Securities elevated its MRVL price objective to $125 from $110 after the partnership reveal, maintaining its Buy recommendation. The investment bank characterized Marvell as “the Switzerland of connectivity,” highlighting its comprehensive support for PCIe, CXL, NVLink, UALink, and Ethernet protocols — a broader compatibility range than competitors Broadcom and AMD offer.
The revised price target reflects a valuation of 28x calendar year 2027 projected earnings, increased from 25x, which BofA noted aligns with AI industry peer multiples. MRVL presently trades at a P/E ratio of 32.3 and maintains a flawless Piotroski Score of 9.
Additional Recent Marvell News
Stifel maintained its Buy rating and $120 price objective for MRVL following the Nvidia partnership disclosure. William Blair similarly reaffirmed its Outperform rating.
Marvell unveiled the Structera S 60260, a 260-lane PCIe 6.0 switch designed specifically for AI data center environments. This launch followed Marvell’s strategic acquisition of XConn Technologies and delivers double the lane capacity compared to current competitive offerings.
Marvell announced a quarterly dividend distribution of $0.06 per share, scheduled for payment on April 30, 2026, to shareholders registered as of April 10, 2026.
Based on TipRanks data, MRVL holds a Strong Buy consensus recommendation built on 22 Buy ratings and 5 Hold ratings from the past three months. The average analyst price objective of $120.06 suggests approximately 21% potential upside from Tuesday’s closing price.
